All Stories

  1. Experience of Real-Life Use of Dalbavancin as an Off-Label Treatment of Complicated Infectious Diseases in a Tertiary Care Hospital Experience
  2. Buenas prácticas docentes y experiencias innovadoras vinculadas con la sostenibilidad
  3. In Silico Model for Predicting CYP2D6-Mediated Drug-Drug Interactions
  4. Antidotes Network
  5. Comment on: “Efficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta-Analysis”
  6. Systematic review for the development of a pharmaceutical and medical products prioritization framework
  7. Programa MADRENUT como herramienta multidisciplinar para mejorar la evaluación de preparados para nutrición enteral y parenteral
  8. Addendum: the use of medicines in exceptional circumstances in Spain: adding perspective to early access
  9. Blood urea levels associated to antidepressant drug treatment: Role of nitrogen and nitric oxide
  10. Pharmaceutical intervention after evaluation of the risk of ictus in elderly patients institutionalized with atrial fibrillation
  11. The use of medicines in exceptional circumstances in Spain: adding perspective to early access
  12. Guidelines for evidence synthesis reporting: medications
  13. Review on strategies to minimize the appearance of multi-drug resistant organism
  14. 2018 ACCP Virtual Poster Symposium
  15. Methadone dosing in patients on ritonavir-boosted-based highly active antiretroviral therapy
  16. Drug Vectoring Systems to Target Drug Delivery Using Nanotechnologies
  17. Time course of the drug-drug interaction of acenocoumarol-miconazole
  18. Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients
  19. Second-Generation Antipsychotics Clinical Pharmacy Plan Developed from Hospital Pharmacy to Primary Health Care
  20. Guías de práctica clínica y fisioterapia basada en la evidencia en pacientes con enfermedad de Parkinson
  21. Evidence-Based Medicine Clinical Practice Guidelines are an opportunity for Hospital Pharmacist
  22. Review of the Available Scientific Evidence on Multiple Chemical Sensitivity Syndrome
  23. Medical Topics